Delivery Order SPE2DB24D2216-SPE2DB26FGLZB
- Not listed
- The Defense Logistics Agency awarded a $3,292.56 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- The Defense Logistics Agency awarded a $5,719.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 18, 2025. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under the company's...
- The Defense Logistics Agency awarded a $30,324 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors (0.5 ml). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor supporting federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 31, 2025. This firm fixed-price, competitively awarded delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a $18,369.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with an ultimate completion date of October 21, 2025. The contract, which is not set-aside and was competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $6,921.52 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, designated as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,410.40 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injectors on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a contract value of $15,251.60. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 12, 2025, with the place of performance located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29.6K to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on September 11, 2025, with completion targeted for September 12, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters location in...
- The Defense Logistics Agency awarded a $41,431.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, which represents a child award under AmerisourceBergen's broader pharmaceutical supply agreement with DLA, specifies performance at the contractor's Conshohocken, Pennsylvania facility with an ultimate completion date of October 23, 2025. This delivery order was awarded through open competition...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB26FGLZBDelivery Order
The Defense Logistics Agency awarded a $16,177.98 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 23, 2025, and performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999.999 billion through December 2026 that enables the contractor to supply medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. As the prime contractor on this delivery order, the company demonstrates its capability to fulfill federal pharmaceutical procurement requirements through open competition. The Zepbound supply under this award supports the Department of Defense's medical supply chain operations, consistent with AmerisourceBergen's extensive portfolio of brand-name and generic medications across multiple therapeutic domains delivered through competitively awarded contracts with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 10/22/25 |